Futura Medical plc (FAMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.1200
+0.0250 (26.32%)
May 2, 2025, 3:52 PM EDT
Futura Medical Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 6.6 | 7.71 | 4.03 | 10.37 | 1.02 | Upgrade
|
Cash & Short-Term Investments | 6.6 | 7.71 | 4.03 | 10.37 | 1.02 | Upgrade
|
Cash Growth | -14.49% | 91.60% | -61.19% | 918.31% | -59.43% | Upgrade
|
Accounts Receivable | 1.27 | 1.15 | 0.07 | 0.01 | 0.01 | Upgrade
|
Other Receivables | 0.22 | 0.38 | 1.02 | 0.91 | 0.53 | Upgrade
|
Receivables | 1.49 | 1.52 | 1.09 | 0.92 | 0.53 | Upgrade
|
Inventory | 0.46 | 0 | - | - | - | Upgrade
|
Prepaid Expenses | 0.96 | 0.09 | 0.2 | 0.07 | 0.02 | Upgrade
|
Total Current Assets | 9.5 | 9.33 | 5.31 | 11.36 | 1.58 | Upgrade
|
Property, Plant & Equipment | 4.09 | 2.48 | 1.16 | 0.44 | 0.04 | Upgrade
|
Total Assets | 13.59 | 11.82 | 6.47 | 11.8 | 1.62 | Upgrade
|
Accounts Payable | 1.49 | 1.01 | 0.32 | 0.98 | 0.18 | Upgrade
|
Accrued Expenses | 1.97 | 1.49 | 1 | 0.99 | 0.58 | Upgrade
|
Current Unearned Revenue | 0.1 | - | - | - | - | Upgrade
|
Other Current Liabilities | 0.29 | 3.85 | 0.43 | 0.11 | - | Upgrade
|
Total Current Liabilities | 3.84 | 6.34 | 1.75 | 2.08 | 0.77 | Upgrade
|
Long-Term Unearned Revenue | 0.34 | - | - | - | - | Upgrade
|
Other Long-Term Liabilities | 0.44 | - | - | - | - | Upgrade
|
Total Liabilities | 4.63 | 6.34 | 1.75 | 2.08 | 0.77 | Upgrade
|
Common Stock | 0.61 | 0.6 | 0.58 | 0.57 | 0.49 | Upgrade
|
Additional Paid-In Capital | 71.24 | 71.07 | 66.55 | 66.38 | 52.81 | Upgrade
|
Retained Earnings | -64.03 | -67.35 | -63.72 | -58.55 | -53.77 | Upgrade
|
Comprehensive Income & Other | 1.15 | 1.15 | 1.32 | 1.32 | 1.32 | Upgrade
|
Shareholders' Equity | 8.96 | 5.48 | 4.72 | 9.72 | 0.85 | Upgrade
|
Total Liabilities & Equity | 13.59 | 11.82 | 6.47 | 11.8 | 1.62 | Upgrade
|
Net Cash (Debt) | 6.6 | 7.71 | 4.03 | 10.37 | 1.02 | Upgrade
|
Net Cash Growth | -14.49% | 91.60% | -61.19% | 918.31% | -59.43% | Upgrade
|
Net Cash Per Share | 0.02 | 0.03 | 0.01 | 0.04 | 0.00 | Upgrade
|
Filing Date Shares Outstanding | 303.7 | 301.41 | 288.05 | 287.15 | 245.63 | Upgrade
|
Total Common Shares Outstanding | 303.7 | 301.41 | 288.05 | 287.15 | 245.63 | Upgrade
|
Working Capital | 5.66 | 2.99 | 3.56 | 9.28 | 0.81 | Upgrade
|
Book Value Per Share | 0.03 | 0.02 | 0.02 | 0.03 | 0.00 | Upgrade
|
Tangible Book Value | 8.96 | 5.48 | 4.72 | 9.72 | 0.85 | Upgrade
|
Tangible Book Value Per Share | 0.03 | 0.02 | 0.02 | 0.03 | 0.00 | Upgrade
|
Machinery | 4.53 | 2.8 | 1.35 | 0.61 | 0.19 | Upgrade
|
Updated Sep 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.